Natera announced three appointments within its senior leadership team, effective immediately. John Fesko has been promoted to president and chief business officer, with oversight of reimbursement strategy and market access, patient operations and experience, marketing and communications, government affairs, business and market development, pharmaceutical services, and international commercial operations and strategy. Solomon Moshkevich, president of clinical diagnostics, joined Natera in 2011.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NTRA: